Clinical trial and real-world data provide evidence that inhaled nitric oxide is effective for reducing pulmonary hypertension in the perioperative setting.
High dose inhaled nitric oxide resulted in improvements in physical activity and other outcomes in patients at risk for pulmonary hypertension-associated fibrotic interstitial lung disease.
Patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc) who...
Patients at greatest risk of dying from PAH may be identified through cardiac MRI and the information the noninvasive scan provides about the functional level of the heart’s right ventricle.
Read More
In addition to suppressing tumors, the protein tuberous sclerosis complex 2 (TSC2) may play a role in preventing or treating pulmonary arterial hypertension (PAH).
Read More
Treatment with selexipag versus placebo improved clinical outcomes in patients with pulmonary arterial hypertension (PAH) regardless of the time from diagnosis to drug initiation.
Read More
Development of pulmonary arterial hypertension (PAH) may be related to increased production of Nestin protein in the pulmonary vasculature, a Plos One study reports.
Read More
Research reports that male sex may be predictive of right ventricular dysfunction in some pulmonary hypertension patients.
Read More
RTs may find it difficult to choose between available inhaled pulmonary vasodilators (IPVs)—inhaled nitric oxide or nebulized epoprostenol—to treat pulmonary hypertension.
Read More
Preterm infants born younger than 29 weeks’ gestational age who were treated for pulmonary...
Read More
The American Lung Association will host a Lung Force Expo on June 15 in Kansas City, Mo.
Read More
Adenotonsillectomy resulted in significant improvements in blood pressure for children suffering with obstructive sleep apnea (OSA) and hypertension.
Read More
Temple University Hospital performed 131 lung transplants in 2017, making it the highest-volume...
Read More
The Y chromosome provides protection against pulmonary hypertension and may be the reason the disease is less prevalent among men than women.
Read More
Patients with sarcoidosis frequently develop pulmonary hypertension, which is associated with an 8- to 10-fold increase in mortality among sarcoidosis patients.
Read More